Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP at Columbia University, is quoted in a July 10 CNN Health article on the potential use of BCG, a common vaccine used globally for tuberculosis prevention, to fight COVID-19:

“The nice thing is that it’s given only once. It’s potentially quite feasible to scale up production of the vaccine, if it works and it’s safe,” said Dr. Wafaa El-Sadr, a Columbia University professor of epidemiology and director of ICAP, a global health program.

Read the full story on CNN Health

Read the latest ICAP updates on COVID-19 here


Related Items